IDEXX LABORATORIES INC /DE (IDXX) FY2025 Q1 Balance Sheet
As of 2025-03-31
Balance Sheet
As of 2025-03-31
Swipe to see the full flow
Chart details
IDEXX LABORATORIES INC /DE (IDXX) FY2025 Q1 Balance Sheet
Balance sheet as of 2025-03-31. The chart shows assets, liabilities and equity at that date.
- Assets
- 3,213,689,000 US dollars
- Current assets
- 1,317,613,000 US dollars
- Non-current assets
- 1,896,076,000 US dollars
- Liabilities
- 1,765,676,000 US dollars
- Current liabilities
- 1,136,213,000 US dollars
- Non-current liabilities
- 629,463,000 US dollars
- Equity
- 1,448,013,000 US dollars
- Accounts receivable, net
- 527,464,000 US dollars
- Inventories
- 395,987,000 US dollars
- Other current assets
- 230,192,000 US dollars
- Cash and cash equivalents
- 163,970,000 US dollars
- Property and equipment, net
- 717,624,000 US dollars
- Other long-term assets
- 547,559,000 US dollars
- Goodwill
- 407,486,000 US dollars
- Operating lease right-of-use assets
- 115,999,000 US dollars
- Intangible assets, net
- 107,408,000 US dollars
- Accrued liabilities
- 490,688,000 US dollars
- Credit facility
- 319,500,000 US dollars
- Current portion of long-term debt
- 170,929,000 US dollars
- Accounts payable
- 120,096,000 US dollars
- Current portion of deferred revenue
- 35,000,000 US dollars
- Long-term debt, net of current portion
- 449,799,000 US dollars
- Long-term operating lease liabilities, net of current portion
- 97,004,000 US dollars
- Other long-term liabilities
- 47,731,000 US dollars
- Long-term deferred revenue, net of current portion
- 26,819,000 US dollars
- Deferred income tax liabilities
- 8,110,000 US dollars
- Retained earnings
- 5,575,115,000 US dollars
- Additional paid-in capital
- 1,695,613,000 US dollars
- Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 107,916 shares in 2025 and 107,836 shares in 2024; Outstanding: 80,740 shares in 2025 and 81,604 shares in 2024
- 10,792,000 US dollars
- Deferred stock units: Outstanding: 59 units in 2025 and 60 units in 2024
- 5,856,000 US dollars
- Treasury stock, at cost: 27,176 shares in 2025 and 26,232 shares in 2024
- negative 5,749,272,000 US dollars
- Accumulated other comprehensive loss
- negative 90,091,000 US dollars
- Gross equity (calculated)
- 7,287,376,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.
Chart connections
- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
